
==== Front
Eur J Pediatr
Eur J Pediatr
European Journal of Pediatrics
0340-6199
1432-1076
Springer Berlin Heidelberg Berlin/Heidelberg

39126518
5711
10.1007/s00431-024-05711-3
Research
Cerebral oxygenation during immediate fetal-to-neonatal transition and fidgety movements between six to 20 weeks of corrected age: An ancillary study to the COSGOD III trial
Wolfsberger Christina Helene 12
Schwaberger Bernhard 12
Urlesberger Berndt 12
Scheuchenegger Anna 12
Avian Alexander 3
Hammerl Marlene 4
Kiechl-Kohlendorfer Ursula 4
Griesmaier Elke 4
Pichler Gerhard gerhard.pichler@medunigraz.at

12
1 https://ror.org/02n0bts35 grid.11598.34 0000 0000 8988 2476 Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
2 https://ror.org/02n0bts35 grid.11598.34 0000 0000 8988 2476 Research Unit for Neonatal Micro- and Macrocirculation, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
3 https://ror.org/02n0bts35 grid.11598.34 0000 0000 8988 2476 Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria
4 grid.5361.1 0000 0000 8853 2677 Department of Pediatrics II, Medical University of Innsbruck, Innsbruck, Austria
Communicated by Daniele De Luca

10 8 2024
10 8 2024
2024
183 10 44254433
19 6 2024
24 7 2024
31 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Fidgety movements provide early information about a potential development of cerebral palsy in preterm neonates. The aim was to assess differences in the combined outcome of mortality and fidgety movements defined as normal or pathological in very preterm neonates according to the group allocation in the randomised-controlled multicentre COSGOD III trial. Preterm neonates of two centres participating in the COSGOD III trial, whose fidgety movements were assessed as normal or pathological at six to 20 weeks of corrected age, were analysed. In the COSGOD III trial cerebral oxygen saturation (crSO2) was measured by near-infrared spectroscopy (NIRS) during postnatal transition and guided resuscitation in preterm neonates randomised to the NIRS-group, whereby medical support was according routine, as it was also in the control group. Fidgety movements were classified in normal or abnormal/absent at six to 20 weeks of corrected age. Mortality and fidgety movements of preterm neonates allocated to the NIRS-group were compared to the control-group. Normal outcome was defined as survival with normal fidgety movements. One-hundred-seventy-one preterm neonates were included (NIRS-group n = 82; control-group n = 89) with a median gestational age of 29.4 (27.4–30.4) and 28.7 (26.7–31.0) weeks in the NIRS-group and the control-group, respectively. There were no differences in the combined outcome between the two groups: 90.2% of the neonates in the NIRS-group and 89.9% in the control-group survived with normal outcome (relative risk [95% CI]; 0.96 [0.31–2.62]).

Conclusions: In the present cohort of preterm neonates, monitoring of crSO2 and dedicated interventions in addition to routine care during transition period after birth did not show an impact on mortality and fidgety movements defined as normal or pathological at six to 20 weeks corrected age.

What is Known

• Fidgety movements display early spontaneous motoric pattern and may provide early information about a potential development of cerebral palsy in preterm neonates.

	
 What is New

 • This retrospective observational study of the randomised-controlled multicentre COSGOD III trial is the first study investigating the potential influence of cerebral oxygenation guided resuscitation during postnatal transition period on combined outcome of mortality and fidgety movements up to 20 weeks of corrected age in very preterm neonates.

• This study adds to the growing interest of assessing cerebral oxygenation, that monitoring of cerebral oxygen saturation and dedicated interventions during postnatal transition period according to the COSGOD III trial has no significant influence on mortality and fidgety movements defined as normal or pathological in very preterm neonates.

	

Keywords

Preterm neonates
Immediate neonatal transition
Near infrared spectroscopy
Cerebral oxygen saturation
General movement assessment
Fidgety movements
http://dx.doi.org/10.13039/501100002428 Austrian Science Fund Medical University of GrazOpen access funding provided by Medical University of Graz.

issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmcIntroduction

Very premature birth is associated with a higher risk of impaired neurodevelopmental outcome following a higher rate of neonatal morbidities occurring during the neonatal period [1–4]. Early identification of abnormal neurological behaviour may have a positive impact on long-term neurodevelopmental outcome due to optimising neuroplasticity of the immature brain by accompanying therapies [5]. The Prechtl General Movement Assessment (GMA) performed until 20 weeks of corrected age is of increasing interest to provide predictive information about neonates concerning their neurodevelopment, including impaired neurodevelopmental outcome, cerebral palsy, minor neurological deficits or cognitive impairment [6–10]. General Movements (GMs) are spontaneous and complex movements that can be detected from early fetal life until four to five months of post-term age [5, 7, 11]. The repertoire of spontaneous movement patterns is described in the “global GMA” according to their age: writhing movements (after birth until six to nine weeks of corrected age) and fidgety movements (six to nine weeks until 14 to 20 weeks of corrected age).

Between six and nine weeks after birth, the writhing movements undergo a transformation into fidgety movements. Fidgety movements are characterised by circular movements with a small amplitude, moderate speed, and variable acceleration involving the neck, trunk and limbs, and can be observed until 15 to 20 weeks of corrected age. Fidgety movements can be classified as either normal or pathological. Pathological fidgety movements are further divided into mainly two categories: absence of fidgety movements (no observation of fidgety movements between six to 20 weeks of corrected age), or abnormal fidgety movements, which resemble normal fidgety movements but present themselves with irregular amplitude, speed and jerkiness [8, 12].

The impact of cerebral oxygenation using near-infrared spectroscopy (NIRS) during immediate transition after birth on neurological outcome has been described in two small observational studies analysing cerebral ultrasound findings [13] and GMA [14]. Analysing general movement optimality score (GMOS) as a semi-quantitative method showed impaired GMs, expressed by a lower GMOS, in association with increased burden of cerebral hypoxia within the first 15 min after birth [14].

The reduction of burden of cerebral hypoxia during the immediate transition period, that might improve neurological outcome by cerebral oxygen saturation (crSO2) monitoring guided resuscitation of preterm neonates, has been demonstrated by Pichler et al. 2016 in a randomised pilot feasibility trial (Cerebral Oxygen Saturation to Guide Oxygen Delivery—COSGOD II trial) [15]. In the COSGOD III trial [16], the aim was to increase survival without cerebral injury by crSO2 guided resuscitation. In this randomised-controlled trial, there was a non-significant difference of 4.3% in survival without cerebral injury between the intervention group and the control group.

Beside cerebral injury, various factors including perinatal asphyxia, chorioamnionitis, moderate-to-severe bronchopulmonary dysplasia (BPD) and/or prolonged invasive respiratory support, may contribute to poor neurodevelopmental outcome [17–19].

The aim of the present study was to assess combined outcome defined by mortality until 20 weeks of corrected age and fidgety movements between six to 20 weeks of corrected age in preterm neonates included in the COSGOD III trial. We hypothesised that crSO2 guided transition in addition to routine care during immediate fetal-to-neonatal transition in preterm neonates reduces mortality and/or leads to a more frequent appearance of normal fidgety movements, compared to preterm neonates treated according routine alone.

Methods

Study design

In the present retrospective observational study neonates included in the prospective randomised-controlled COSGOD III multicentre trial, conducted between October 2017 and February 2022, were eligible. The protocol [20] and the primary outcome [16] of the COSGOD III trial have already been published elsewhere.

For this retrospective observational study combined outcome, defined as mortality until 20 weeks of corrected age and fidgety movements performed between six to 20 weeks of corrected age were analysed and compared between the intervention (NIRS) group and control group of the COSGOD III trial. Out of eleven participating centres in the COSGOD III trial two centres performed GMA routinely and were therefore eligible for this analysis: Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Austria and Department of Pediatrics II, Medical University of Innsbruck, Austria. The present study, as an ancillary study to the COSGOD III trial, has been approved by the Regional Committee on Biomedical Ethics of the Medical University of Graz (EC number: 35–438 ex 22/23) and Medical University of Innsbruck (EC number: 1264/2023) and was conducted in accordance with the Declaration of Helsinki. The prospective randomised-controlled COSGOD III multicentre trial was registered at Clinical Trials (Number: NCT06105333).

COSGOD III trial

Preterm neonates < 32 weeks of gestational age, were included in the COSGOD III trial and obtained continuous measurement of cerebral oxygenation during the first 15 min after birth. Before birth, preterm neonates were randomised either to the NIRS group or to the control group. In the intervention group (NIRS group) resuscitation was conducted in accordance with local guidelines and/or with the latest “Resuscitation Consensus Guidelines” [21, 22]. CrSO2 monitoring was visible to the clinical team. Provided that SpO2 was within targets, medical support was changed if crSO2 was less than the 10th centile or above the 90th centile. In the control group, crSO2 values were not visible to the clinical team and resuscitation was performed according to routine. The methods of the COSGOD III trial have been described in more detail elsewhere [16, 20].

Inclusion and exclusion criteria for the present study

Centres that participated in the COSGOD III trial with available data on mortality and routine assessments of fidgety movements between six to 20 weeks of corrected age were included.

Centres with no available data on fidgety movements were excluded from analyses a priori.

Demographic data and neonatal morbidities

Demographic data and neonatal morbidities including cerebral injury and all-cause mortality assessed in the COSGOD III trial were analysed in the present study. Cerebral injury was defined as intraventricular haemorrhage (IVH grade I-IV), or cystic periventricular leukomalacia (cystic PVL grade II-III). Further documented morbidities of the COSGOD III trial were respiratory distress syndrome (IRDS grade I-IV), culture proven sepsis, necrotizing enterocolitis (NEC), BPD defined as oxygen dependency or need of respiratory support at 36 weeks corrected age, retinopathy of prematurity (ROP ≥ grade II) and persistent ductus arteriosus (PDA) with medical and/or surgical intervention.

Fidgety movements

Assessment of fidgety movements was performed between six to 20 weeks of corrected age by video recording of sequences of at least three minutes. The neonates were recorded after feeding, during periods of active wakefulness and lied in a supine position. The assessment had to be restarted when the neonates started crying, fussing or they were in suckling periods. Fidgety movements were documented by clinical staff trained and certified for GMA, who were blinded for the allocation of the neonate in the COSGOD III trial. Fidgety movements were stratified as either normal or pathological, whereby pathological fidgety movements were further divided into two categories: absent (no observation of fidgety movements between six to 20 weeks of corrected age) or abnormal (resembling normal fidgety movements but with irregular amplitude, speed and jerkiness) [8, 12].

Primary outcome

The primary outcome of the present study was the combined outcome of mortality before 20 weeks of corrected age and the appearance of fidgety movements between six to 20 weeks of corrected age. Normal outcome was defined as survival with normal fidgety movements. Poor outcome was defined as mortality or absent/abnormal fidgety movements.

Secondary outcomes

Survival without cerebral injury (IVH, cystic PVL), mortality, IRDS, sepsis, NEC, BPD, ROP and PDA were defined as secondary outcome parameters and were compared between the NIRS group and the control group in the present cohort.

Statistics

Baseline characteristics of neonates are given with median and interquartile range for continuous data and numbers and percentages for categorical data. Comparison of baseline characteristics were done using Mann Whitney U-test for continuous data and Chi-square test or Fisher’s exact test for categorical data. To answer the hypothesis whether combined outcome (mortality and fidgety movements) differ between neonates of the NIRS group and neonates of the control group Chi-square test was used. Relative Risk (RR) with 95% confidence interval (95% CI) were calculated. Secondary parameters were compared between the two groups using Mann Whitney U-test for continuous data and Chi-square test or Fisher’s exact test for categorical data. Statistical analysis was performed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA).

Results

In the two centres, 178 preterm neonates (Graz n = 112; Innsbruck n = 66) were included into the COSGOD III trial and were therefore eligible for the present study. Seven preterm neonates were excluded as there was no assessment of fidgety movements performed between six to 20 weeks of corrected age (Graz n = 4, Innsbruck n = 3). Thus, for the final analysis 82 preterm neonates were included in the NIRS group (Graz n = 52; Innsbruck n = 30) and 89 in the control group (Graz n = 56; Innsbruck n = 33) (Fig. 1. Study flow chart).Fig. 1 Study flow chart

Demographic data of the included neonates are presented in Table 1. The median gestational age was 29.4 (27.4–30.4) weeks in the NIRS group and 28.7 (26.7–31.0) weeks in the control group. The median birth weight was 1190 (900–1450) grams and 1135 (900–1420) grams in the NIRS group and in the control group, respectively. There were no significant differences in gestational age (p = 0.372) and birth weight (p = 0.344). Table 1 Neonatal characteristics and maternal and fetal causes for preterm birth of the included very preterm neonates in the NIRS group and in the control group

	NIRS group
n = 82	Control group
n = 89	p-value	
Gestational age, weeks, median (IQR)	29.4 (27.4–30.4)	28.7 (26.7–31.0)	0.372	
Gestational age < 28 weeks, n (%)	22 (26.8)	31 (34.8)	0.258	
Gestational age > 28 weeks, n (%)	60 (73.2)	58 (65.2)	0.449	
Birth weight, g, median (IQR)	1190 (900–1450)	1135 (900–1420)	0.344	
Male/female, n (%)	46/36 (56.1/43.9)	55/34 (61.8/38.2)	0.449	
Umbilical artery pH, median (IQR)	7.33 (7.28–7.37)	7.32 (7.28–7.36)	0.509	
Apgar 1, median (IQR)	8.0 (6.0–8.0)	7.0 (6.0–8.0)	0.254	
Apgar 5, median (IQR)	8.0 (8.0–9.0)	8.0 (8.0–9.0)	0.066	
Apgar 10, median (IQR)	9.0 (9.0–9.0)	9.0 (9.0–9.0)	0.125	
Maternal causes for preterm birth	
Antepartum bleeding, n (%)	12 (14.6)	4 (4.5)	0.023	
Chorioamnionitis, n (%)	21 (25.6)	30 (33.7)	0.248	
Premature rupture of membranes, n (%)	21 (25.6)	23 (25.8)	0.927	
Preeclampsia, n (%)	16 (19.5)	20 (22.5)	0.635	
Gestational diabetes, n (%)	1 (1.2)	4 (4.5)	0.370	
Others, n (%)	16 (19.5)	26 (29.2)	0.141	
Fetal causes for preterm birth	
Intrauterine growth restriction, n (%)	15 (18.3)	13 (16.9)	0.805	
Fetal bradycardia, n (%)	14 (17.1)	11 (12.4)	0.373	
Pathological doppler sonography, n (%)	13 (15.9)	12 (13.5)	0.373	
Multiples, n (%)	10 (12.2)	8 (9.0)	0.495	
Others, n (%)	3 (3.7)	2 (2.3)	0.584	

In the NIRS group 89.0% (n = 73) and in the control group 94.4% (n = 84) (p = 0.202) were delivered by Caesarean section and 11.0% (n = 9) and 5.6% (n = 5) in the NIRS group and in the control group were delivered spontaneously, respectively. The time until cord clamping did not differ between the groups (p = 0.708). Cord clamping was performed at less than 30 s in 80.8% (n = 63) in the NIRS group and in 75.3% (n = 61) in the control group. The cord was clamped after 30 to 60 s in 3.9% (n = 3) in the NIRS group and in 4.9% (n = 4) in the control group, whereby cord clamping was delayed more than 60 s in 15.4% (n = 12) in the NIRS group and in 19.8% (n = 16) in the control group. Maternal and fetal causes for preterm birth are displayed in Table 1.

Provided respiratory support and medications during the first 15 min after birth and within the first 24 h after birth are presented in Table 2. Table 2 Interventions during first 15 min after birth and the first 24 h after birth in very preterm neonates of the NIRS group and the control group

	NIRS group
n = 82	Control group
n = 89	p-value	
First 15 min after birth	
Supplemental oxygen, n (%)	81 (98.8)	86 (96.6)	0.622	
No respiratory support, n (%)	1 (1.2)	1 (1.1)	0.930	
Mask continuous positive pressure, n (%)	23 (28.1)	29 (32.6)		
Mask positive pressure ventilation, n (%)	54 (65.9)	55 (61.8)		
Intubation, n (%)	4 (4.9)	4 (4.5)		
Chest compressions, n (%)	0 (0.0)	2 (2.3)	0.500	
Caffeine, n (%)	42 (52.5)	53 (62.9)	0.171	
Adrenaline, n (%)	0 (0.0)	0 (0.0)	-	
Surfactant, n (%)	3 (3.7)	4 (4.5)	1.000	
Volume, n (%)	3 (3.7)	0 (0.0)	0.108	
Others, n (%)	4 (4.9)	2 (2.3)	0.433	
First 24 h after birth	
Surfactant, n (%)	60 (73.2)	65 (73.0)	0.984	
No respiratory support, n (%)	2 (2.4)	5 (5.6)	0.616	
Non-invasive ventilation, n (%)	66 (80.5)	69 (77.5)		
Mechanical ventilation, n (%)	14 (17.1)	15 (16.9)		

Primary outcome

Fidgety movements were analysed at 12.1 (11.9–12.7) weeks of corrected age in the NIRS group and at 12.1 (12.0–12.6) weeks in the control group (p = 0.819). No difference in the combined primary outcome (survival and normal fidgety movements between six to 20 weeks of corrected age) was observed comparing the NIRS group to the control group (RR [95%CI] 0.96 [0.31–2.62], p = 0.938) (Table 3). Table 3 Combined outcome mortality and fidgety movements of very preterm neonates in the NIRS group and in the control group. Poor outcome is defined as mortality before 20 weeks of corrected age or pathological fidgety movements between six to 20 weeks of corrected age. Neonatal morbidities at term age or before discharge of very preterm neonates in the NIRS group and in the control group. Data are presented as n (%). Relative Risk [95% CI] and p-value of the Relative Risk are provided

	NIRS group
n = 82	Control group
n = 89	Relative Risk [95% CI]	p-value	
Combined outcome mortality and fidgety movements	
  Normal outcome	74 (90.2)	80 (89.9)	0.96 [0.31–2.62]	0.938	
  Poor outcome	8 (9.8)	9 (10.1)			
Neonatal morbidities at term age or before discharge	
  Death and/or cerebral injury, n (%)	8 (9.8)	17 (19.1)	0.51 [0.23–1.12]	0.084	
  Death, n (%)	4 (4.9)	4 (4.5)	1.00 [0.93–1.06]	1.000	
  IVH any grade, n (%)	6 (7.3)	14 (15.7)	0.46 [0.19–1.15]	1.000	
  No IVH, n (%)	76 (92.7)	75 (84.3)		0.25	
  IVH I-II, n (%)	4 (4.9)	10 (11.2)	
  IVH III-IV, n (%)	2 (2.4)	4 (4.5)	
  Cystic PVL any grade, n (%)	1 (1.2)	1 (1.1)	1.09 [0.07–17.07]	1.000	
  No cystic PVL, n (%)	81 (98.8)	88 (98.9)		0.731	
  Cystic PVL II, n (%)	0 (0.0)	1 (1.1)	
  Cystic PVL III, n (%)	1 (1.2)	0 (0.0)	
  IRDS any grade, n (%)	77 (93.9)	84 (94.4)	0.99 [0.92–1.07]	1.000	
  No IRDS, n (%)	5 (6.1)	5 (5.6)		0.619	
  IRDS grade 1–2, n (%)	67 (81.7)	68 (76.4)	
  IRDS grade 3–4, n (%)	10 (12.2)	16 (18.0)	
  Culture proven sepsis, n (%)	19 (23.2)	23 (25.8)	0.90 [0.53–1.52]	0.164	
  NEC any grade, n (%)	3 (3.7)	1 (1.1)	3.26 [0.35–30.68]	0.351	
  BPD, n (%)	7 (8.5)	9 (10.1)	0.84 [0.32–2.16]	0.125	
  ROP grade ≥ 2, n (%)	7 (8.5)	11 (12.4)	0.69 [0.28–1.70]	0.463	
  PDA with interventions, n (%)	4 (4.9)	9 (10.1)	0.48 [0.15–1.51]	0.197	
BDP bronchopulmonary dysplasia, IRDS infant respiratory distress syndrome, IVH intraventricular haemorrhage, NEC necrotizing enterocolitis, PDA persistent ductus arteriosus, PVL periventricular leukomalacia, ROP retinopathy of prematurity

Secondary outcome

Eight preterm neonates died before 20 weeks of corrected age (n = 4 NIRS group; n = 4 control group). Survival without cerebral injury was 90.2% in the NIRS group and 80.9% in the control group (RR [95% CI] 1.12 [0.99–1.26], p = 0.084). Secondary outcomes including IVH, cystic PVL, IRDS, EOS, NEC, BPD, ROP and PDA with interventions are displayed in Table 3.

Discussion

This is the first study, investigating the potential influence of cerebral oxygenation guided resuscitation during immediate fetal-to-neonatal transition period on combined outcome of mortality and fidgety movements defined as normal or pathological in very preterm neonates. We did not observe substantial impact on mortality and fidgety movements in the NIRS group when compared to the control group.

Pathological fidgety movements, especially their absence, have been described as a predictive value for a later development of cerebral palsy [23, 24]. Whereby, a combination of both, cerebral injury and absence of fidgety movements have the highest predictive value. Abnormal GMs or absence of fidgety movements in preterm neonates with cerebral morbidities, especially PVL, are explained by disruptions of the corticospinal projection as a consequence of brain lesions [25, 26]. In our present cohort, the proportion of analysed preterm neonates with cerebral injuries was quite low. Therefore, the overall risk for the development of a cerebral palsy in our observed cohort is very low, and it may be speculated that the results of the present study may be more pronounced in cases of a higher proportion of cerebral injuries.

Beside the high predictive value for cerebral palsy in case of absent fidgety movements, no significant association of abnormal/absent fidgety movements and Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III) has been described [27]. The potential influence of crSO2 on long-term outcome at a corrected age of two years, assessed by BSID-III has been observed by Wolfsberger et al. [28]. They stated that preterm neonates with a very low gestational age and birth weight with poor long-term outcome (mortality, testing not possible due to cognitive impairment and/or BSID-III ≤ 70), showed significant lower crSO2 values during immediate fetal-to-neonatal transition period, when being compared to preterm neonates with favourable outcome.

The results of fidgety movements between six to 20 weeks of corrected age can be influenced by different perinatal factors and morbidities. The predictive value of fidgety movements also depends on the postnatal age / corrected age of the neonate at time point of assessment [25]. The mean corrected age at time point of assessment of fidgety movements of the included preterm neonates in our cohort was 12 weeks. According to literature, the optimal period for evaluating fidgety movements is generally regarded between ten to 12 weeks post-term [8]. Based on that, results of fidgety movements demonstrated in the present study were assessed in the ideal period concerning evaluation of neurobehavioral repertoire. Beside postnatal age, severe infections during early neonatal period may have an impact on fidgety movements, with a higher proportion of abnormal/absent fidgety movements being observed in neonates with infections [29]. In the present study no difference in culture proven sepsis was described between the two groups. Therefore, the similar distribution of this influencing factor can be reassuring for interpretation of the present results. Furthermore, a retrospective study described a higher percentage of abnormal fidgety movements in very preterm neonates who received systemic corticosteroids compared to neonates of the non-corticosteroid group [30]. In our present study, unfortunately no information about therapy with systemic corticosteroids were available. Gestational age and severity of illnesses, however, were similar between the two groups suggesting also similar corticosteroid application.

It has been described that serial GMAs provide a more accurate information about the early neurodevelopmental state of the analysed neonate [31, 32]. Changes in the quality of the GMs, can be influenced by different factors, including provided medications or interventions, as described above. Multiple GMAs at different time points might help to rule out these potential influencing factors [31, 32]. In our present cohort of neonates, serial GMAs have only been performed in a few preterm neonates, therefore serial GMA analysis was not possible, which might be a limiting factor.

Taking the results of the present study into account it may be assumed that crSO2 monitoring with dedicated interventions according to the COSGOD III trial cannot influence mortality up to 20 weeks and the appearance of fidgety movements between six to 20 weeks of corrected age in very preterm neonates. This is in contrast to already published data observing the potential influence of burden of cerebral hypoxia within the first 15 min after birth on GMA, and GMOS performed between 36 and 40 weeks postmenstrual age [14]. These results suggest that cerebral oxygenation during immediate fetal-to-neonatal transition period affect GMs at term age. Pansy et al. [14] suggested burden of hypoxia defined by crSO2 values below the 10th percentile [33] might have an influence on cerebral injury and thus on neonatal neurodevelopmental outcome. Different assumptions may explain the discrepancy between our present findings to already published data describing an influence of crSO2 on short-term neurological outcome. Writhing movements, as investigated in the study of Pansy et al. [14], and fidgety movements cannot be equated. Souza et al. [34] observed potential correlation between writhing movements and fidgety movements in context to assess the time point when writhing movements are predictive for fidgety movements. They described that abnormal writhing movements at the neonatal intensive care unit or up to five weeks of corrected age, were only in 85% in accordance to absent fidgety movements nine to 20 weeks of corrected age.

The major strength of the study is the amount of overall included preterm neonates with available fidgety movements (n = 163) of a multicentre study. The main limitation of this study was the overall number of analysed preterm neonates with abnormal/absent fidgety movements. This, however, may be explained by the overall low proportion of preterm neonates with a cerebral injury, especially with a diagnosis of cystic PVL.

Conclusion

Cerebral oxygen saturation monitoring combined with dedicated treatment guidelines in accordance to the protocol of the COSGOD III trial during immediate fetal-to-neonatal transition period was not associated with an improvement on combined outcome, death and/or pathological fidgety movements between six to 20 weeks of corrected age.

Abbreviations

BSID-III Bayley Scales of Infant and Toddler Development-Third Edition

BPD Bronchopulmonary dysplasia

crSO2 Cerebral oxygen saturation

GMA General Movement Assessment

GMOS General movement optimality score

GMs General Movements

IRDS Infant respiratory distress syndrome

IVH Intraventricular haemorrhage

NIRS Near-infrared spectroscopy

NEC Necrotizing enterocolitis

PVL Periventricular leukomalacia

PDA Persistent ductus arteriosus

ROP Retinopathy of prematurity

Acknowledgements

We would like to express our gratitude to the parents for giving permission to investigate their infants and to the team of midwives, nurses, laboratory staff, and physicians involved in their care.

Collaborators

Division of Neonatology, Department of Pediatrics, Medical University of Graz, Graz, Austria: Marlies Bruckner, Corinna Binder-Heschl, Daniel Pfurtscheller, Johann Martensen, Nina Höller, Evelyn Ziehenberger, Lukas Mileder;

Comprehensive Center for Pediatrics, Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria: Katharina Goeral, Julia Buchmayer, Katrin Klebermass-Schrehof, Angelika Berger (local principal investigator), Sigrid Baumgartner, Agnes Grill, Michaela Mayr, Judith Rittenschober-Boehm, Michael Schneider;

Department of Pediatrics II, Neonatology, Medical University of Innsbruck, Innsbruck, Austria: Christina Schreiner, Vera Neubauer, Peter Wöckinger, Anna Posod;

Neonatal Intensive Care Unit, Department for Perinatology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Slovenia:

Tina Perme, Lilijana Kornhauser-Cerar, Anja Marolt, Ana Dimnik, Vlasta Lubej Kurtovič;

Infant Centre, University College Cork, Cork University Maternity Hospital, Cork, Ireland:

Eugene M Dempsey, Christoph E Schwarz, Garvey Aisling, Jurate Panaviene, David Healy, Nahla Ahmed, Ita Herlihy;

Department of Neonatology, University Children’s Hospital of Tübingen, Germany:

Laila Springer, Kerstin Gründler, Axel Franz;

Neonatologia e Terapia Intensiva Neonatale (TIN) Ospedale dei Bambini “V.Buzzi,” Milano, Italia: Gianluca Lista, Ilaria Stucchi, Francesca Castoldi, Francesco Cavigioli;

II Department of Neonatology, Neonatal Biophysical Monitoring and Cardiopulmonary Therapies Research Unit, Chair of Neonatology, Poznan University of Medical Sciences, Poznan, Poland:

Tomasz Szczapa, Lukasz Karpinski.

Ginekologiczno Położniczy Szpital Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznańiu, Poznań, Poland: Zuzanna Kozłowska, Marcin Minta, Zuzanna Owsiańska, Sonia Kahtan, Natalia Neumann-Klimasińska, Karolina Wróbel, Agata Kubiaczyk, Katarzyna Kosik, Katarzyna Olek, Michalina Bugiera, Julita Porwolik, Agnieszka Basiukajć, Elzbieta Czapla, Wojciech Łukaszuk, Katarzyna Gryczka, Dobrochna Naskręcka, Jan Mazela, Marta Szymankiewicz-Bręborowicz;

Division of Neonatology and Pediatric Intensive Care Medicine, Center for Pediatrics and Adolescent Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany:

Hans Fuchs, Daniel Klotz, Jana Baumgartner; Institute for Maternal and.

Child Health, “IRCCS Burlo Garofolo,” Trieste, Italy:

Jenny Bua, Jana Bembich, Laura Travan;

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada:

Georg M Schmölzer, Brenda Law, Po-Yin Cheung.'

Authors’ Contributions

CHW and GP conceptualised and designed the ancillary study. GP and UKK coordinated this ancillary study at different sites. All authors contributed to the acquisition and preparation of study data. AV, CHW and GP performed the statistical analyses. All authors contributed to interpretation of the findings. CHW and GP drafted the manuscript. All authors critically revised the manuscript for important intellectual content. All authors approved the final manuscript. GP obtained funding for the COSGOD III trial. The corresponding author GP attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.

Funding

Open access funding provided by Medical University of Graz. No funding was received for the analysis of the data presented in the submitted manuscript, funders had no influence on analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.

The COSGOD III trial was funded by the Austrian Science Fund (Fonds zur Förderung der wissenschaftlichen Forschung [FWF] Austria), through an unconditional and unrestricted grant (KLI 586-B31). HRB Clinical Research Facility at University College Cork supported the study at the Infant Centre, University College Cork, Cork University Maternity Hospital, Cork, Ireland. GMS was a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, a National New Investigator of the Heart and Stroke Foundation Canada, and an Alberta New Investigator of the Heart and Stroke Foundation Alberta. This research was facilitated by the Women and Children’s Health Research Institute through the support of the Stollery Children’s Hospital Foundation.

Data availability

Data are available on reasonable request.

Declarations

Competing interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Pascal A Govaert P Oostra A Naulaers G Ortibus E Van den Broeck C Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review Dev Med Child Neurol 2018 60 4 342 355 10.1111/dmcn.13675 29350401
Pascal A, Govaert P, Oostra A, Naulaers G, Ortibus E, Van den Broeck C (2018) Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev Med Child Neurol 60(4):342–355. 10.1111/dmcn.1367529350401
2. Rogers EE Hintz SR Early neurodevelopmental outcomes of extremely preterm infants Semin Perinatol 2016 40 8 497 509 10.1053/j.semperi.2016.09.002 27865437
Rogers EE, Hintz SR (2016) Early neurodevelopmental outcomes of extremely preterm infants. Semin Perinatol 40(8):497–509. 10.1053/j.semperi.2016.09.00227865437
3. Platt MJ Outcomes in preterm infants Public Health 2014 128 5 399 403 10.1016/j.puhe.2014.03.010 24794180
Platt MJ (2014) Outcomes in preterm infants. Public Health 128(5):399–403. 10.1016/j.puhe.2014.03.01024794180
4. Asztalos EV Church PT Riley P Fajardo C Shah PS Network CN Investigators C-U Neonatal Factors Associated with a Good Neurodevelopmental Outcome in Very Preterm Infants Am J Perinatol 2017 34 4 388 396 10.1055/s-0036-1592129 27588931
Asztalos EV, Church PT, Riley P, Fajardo C, Shah PS, Network CN, Investigators C-U (2017) Neonatal Factors Associated with a Good Neurodevelopmental Outcome in Very Preterm Infants. Am J Perinatol 34(4):388–396. 10.1055/s-0036-159212927588931
5. Glass HC Li Y Gardner M Barkovich AJ Novak I McCulloch CE Rogers EE Early Identification of Cerebral Palsy Using Neonatal MRI and General Movements Assessment in a Cohort of High-Risk Term Neonates Pediatr Neurol 2021 118 20 25 10.1016/j.pediatrneurol.2021.02.003 33714922
Glass HC, Li Y, Gardner M, Barkovich AJ, Novak I, McCulloch CE, Rogers EE (2021) Early Identification of Cerebral Palsy Using Neonatal MRI and General Movements Assessment in a Cohort of High-Risk Term Neonates. Pediatr Neurol 118:20–25. 10.1016/j.pediatrneurol.2021.02.00333714922
6. Olsen JE Allinson LG Doyle LW Brown NC Lee KJ Eeles AL Cheong JLY Spittle AJ Preterm and term-equivalent age general movements and 1-year neurodevelopmental outcomes for infants born before 30 weeks' gestation Dev Med Child Neurol 2018 60 1 47 53 10.1111/dmcn.13558 28940492
Olsen JE, Allinson LG, Doyle LW, Brown NC, Lee KJ, Eeles AL, Cheong JLY, Spittle AJ (2018) Preterm and term-equivalent age general movements and 1-year neurodevelopmental outcomes for infants born before 30 weeks’ gestation. Dev Med Child Neurol 60(1):47–53. 10.1111/dmcn.1355828940492
7. Aizawa CYP Einspieler C Genovesi FF Ibidi SM Hasue RH The general movement checklist: A guide to the assessment of general movements during preterm and term age J Pediatr (Rio J) 2021 97 4 445 452 10.1016/j.jped.2020.09.006 33147443
Aizawa CYP, Einspieler C, Genovesi FF, Ibidi SM, Hasue RH (2021) The general movement checklist: A guide to the assessment of general movements during preterm and term age. J Pediatr (Rio J) 97(4):445–452. 10.1016/j.jped.2020.09.00633147443
8. Prechtl HF Einspieler C Cioni G Bos AF Ferrari F Sontheimer D An early marker for neurological deficits after perinatal brain lesions Lancet 1997 349 9062 1361 1363 10.1016/S0140-6736(96)10182-3 9149699
Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D (1997) An early marker for neurological deficits after perinatal brain lesions. Lancet 349(9062):1361–1363. 10.1016/S0140-6736(96)10182-39149699
9. Bosanquet M Copeland L Ware R Boyd R A systematic review of tests to predict cerebral palsy in young children Dev Med Child Neurol 2013 55 5 418 426 10.1111/dmcn.12140 23574478
Bosanquet M, Copeland L, Ware R, Boyd R (2013) A systematic review of tests to predict cerebral palsy in young children. Dev Med Child Neurol 55(5):418–426. 10.1111/dmcn.1214023574478
10. Bruggink JL Einspieler C Butcher PR Van Braeckel KN Prechtl HF Bos AF The quality of the early motor repertoire in preterm infants predicts minor neurologic dysfunction at school age J Pediatr 2008 153 1 32 39 10.1016/j.jpeds.2007.12.047 18571531
Bruggink JL, Einspieler C, Butcher PR, Van Braeckel KN, Prechtl HF, Bos AF (2008) The quality of the early motor repertoire in preterm infants predicts minor neurologic dysfunction at school age. J Pediatr 153(1):32–39. 10.1016/j.jpeds.2007.12.04718571531
11. Prechtl HF General movement assessment as a method of developmental neurology: new paradigms and their consequences. The, 1999 Ronnie MacKeith lecture Dev Med Child Neurol 2001 43 12 836 842 11769272
Prechtl HF (2001) General movement assessment as a method of developmental neurology: new paradigms and their consequences. The, 1999 Ronnie MacKeith lecture. Dev Med Child Neurol 43(12):836–84211769272
12. Einspieler C Prechtl HF Ferrari F Cioni G Bos AF The qualitative assessment of general movements in preterm, term and young infants–review of the methodology Early Hum Dev 1997 50 1 47 60 10.1016/s0378-3782(97)00092-3 9467693
Einspieler C, Prechtl HF, Ferrari F, Cioni G, Bos AF (1997) The qualitative assessment of general movements in preterm, term and young infants–review of the methodology. Early Hum Dev 50(1):47–60. 10.1016/s0378-3782(97)00092-39467693
13. Baik N Urlesberger B Schwaberger B Schmölzer GM Avian A Pichler G Cerebral haemorrhage in preterm neonates: does cerebral regional oxygen saturation during the immediate transition matter? Arch Dis Child Fetal Neonatal Ed 2015 100 5 F422 F427 10.1136/archdischild-2014-307590 26066762
Baik N, Urlesberger B, Schwaberger B, Schmölzer GM, Avian A, Pichler G (2015) Cerebral haemorrhage in preterm neonates: does cerebral regional oxygen saturation during the immediate transition matter? Arch Dis Child Fetal Neonatal Ed 100(5):F422–F427. 10.1136/archdischild-2014-30759026066762
14. Pansy J Baik N Schwaberger B Scheuchenegger A Pichler-Stachl E Avian A Schmölzer GM Urlesberger B Pichler G Cerebral hypoxia during immediate transition after birth and short term neurological outcome Early Hum Dev 2017 110 13 15 10.1016/j.earlhumdev.2017.04.009 28472725
Pansy J, Baik N, Schwaberger B, Scheuchenegger A, Pichler-Stachl E, Avian A, Schmölzer GM, Urlesberger B, Pichler G (2017) Cerebral hypoxia during immediate transition after birth and short term neurological outcome. Early Hum Dev 110:13–15. 10.1016/j.earlhumdev.2017.04.00928472725
15. Pichler G, Urlesberger B, Baik N, Schwaberger B, Binder-Heschl C, Avian A, Pansy J, Cheung PY, Schmölzer GM (2016) Cerebral Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates for the Immediate Transition after Birth: A 2-Center Randomized Controlled Pilot Feasibility Trial. J Pediatr 170:73–8.e1–4. 10.1016/j.jpeds.2015.11.053. Erratum in: (2017) J Pediatr 187:338. 10.1016/j.jpeds.2017.05.028.
16. Pichler G Goeral K Hammerl M Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial BMJ 2023 380 e072313 10.1136/bmj-2022-072313.Erratum.In:(2023)BMJ381:p1102 36693654
Pichler G, Goeral K, Hammerl M et al (2023) Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial. BMJ 380:e072313. 10.1136/bmj-2022-072313.Erratum.In:(2023)BMJ381:p110236693654
17. Hee Chung E Chou J Brown KA Neurodevelopmental outcomes of preterm infants: a recent literature review Transl Pediatr 2020 9 Suppl 1 S3 S8 10.21037/tp.2019.09.10 32206579
Hee Chung E, Chou J, Brown KA (2020) Neurodevelopmental outcomes of preterm infants: a recent literature review. Transl Pediatr 9(Suppl 1):S3–S8. 10.21037/tp.2019.09.1032206579
18. Woythaler M Neurodevelopmental outcomes of the late preterm infant Semin Fetal Neonatal Med 2019 24 1 54 59 10.1016/j.siny.2018.10.002 30322826
Woythaler M (2019) Neurodevelopmental outcomes of the late preterm infant. Semin Fetal Neonatal Med 24(1):54–59. 10.1016/j.siny.2018.10.00230322826
19. Hollanders JJ Schaëfer N van der Pal SM Oosterlaan J Rotteveel J Finken MJJ on behalf of the Dutch POPS-19 Collaborative Study Group Long-Term Neurodevelopmental and Functional Outcomes of Infants Born Very Preterm and/or with a Very Low Birth Weight Neonatology 2019 115 4 310 319 10.1159/000495133 30836372
Hollanders JJ, Schaëfer N, van der Pal SM, Oosterlaan J, Rotteveel J, Finken MJJ, on behalf of the Dutch POPS-19 Collaborative Study Group (2019) Long-Term Neurodevelopmental and Functional Outcomes of Infants Born Very Preterm and/or with a Very Low Birth Weight. Neonatology 115(4):310–319. 10.1159/00049513330836372
20. Pichler G Baumgartner S Biermayr M Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial Trials 2019 20 1 178 10.1186/s13063-019-3258-y 30894226
Pichler G, Baumgartner S, Biermayr M et al (2019) Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial. Trials 20(1):178. 10.1186/s13063-019-3258-y30894226
21. J Wyllie J Bruinenberg CC Roehr M Rüdiger D Trevisanuto B Urlesberger 2015 European Resuscitation Council Guidelines for Resuscitation 2015: Section 7 Resuscitation and support of transition of babies at birth Resuscitation 95 249 263 10.1016/j.resuscitation.2015.07.029
22. Madar J Roehr CC Ainsworth S European Resuscitation Council Guidelines 2021: Newborn resuscitation and support of transition of infants at birth Resuscitation 2021 161 291 326 10.1016/j.resuscitation.2021.02.014 33773829
Madar J, Roehr CC, Ainsworth S et al (2021) European Resuscitation Council Guidelines 2021: Newborn resuscitation and support of transition of infants at birth. Resuscitation 161:291–326. 10.1016/j.resuscitation.2021.02.01433773829
23. Prechtl HF Qualitative changes of spontaneous movements in fetus and preterm infant are a marker of neurological dysfunction Early Hum Dev 1990 23 3 151 158 10.1016/0378-3782(90)90011-7 2253578
Prechtl HF (1990) Qualitative changes of spontaneous movements in fetus and preterm infant are a marker of neurological dysfunction. Early Hum Dev 23(3):151–158. 10.1016/0378-3782(90)90011-72253578
24. Spittle AJ Spencer-Smith MM Cheong JL Eeles AL Lee KJ Anderson PJ Doyle LW General movements in very preterm children and neurodevelopment at 2 and 4 years Pediatrics 2013 132 2 e452 e458 10.1542/peds.2013-0177 23878041
Spittle AJ, Spencer-Smith MM, Cheong JL, Eeles AL, Lee KJ, Anderson PJ, Doyle LW (2013) General movements in very preterm children and neurodevelopment at 2 and 4 years. Pediatrics 132(2):e452–e458. 10.1542/peds.2013-017723878041
25. Ferrari F Frassoldati R Berardi A Di Palma F Ori L Lucaccioni L Bertoncelli N Einspieler C The ontogeny of fidgety movements from 4 to 20weeks post-term age in healthy full-term infants Early Hum Dev 2016 103 219 224 10.1016/j.earlhumdev.2016.10.004 27825041
Ferrari F, Frassoldati R, Berardi A, Di Palma F, Ori L, Lucaccioni L, Bertoncelli N, Einspieler C (2016) The ontogeny of fidgety movements from 4 to 20weeks post-term age in healthy full-term infants. Early Hum Dev 103:219–224. 10.1016/j.earlhumdev.2016.10.00427825041
26. Ferrari F Cioni G Einspieler C Roversi MF Bos AF Paolicelli PB Ranzi A Prechtl HF Cramped synchronized general movements in preterm infants as an early marker for cerebral palsy Arch Pediatr Adolesc Med 2002 156 5 460 467 10.1001/archpedi.156.5.460 11980551
Ferrari F, Cioni G, Einspieler C, Roversi MF, Bos AF, Paolicelli PB, Ranzi A, Prechtl HF (2002) Cramped synchronized general movements in preterm infants as an early marker for cerebral palsy. Arch Pediatr Adolesc Med 156(5):460–467. 10.1001/archpedi.156.5.46011980551
27. Teschler U Dathe AK Heuser-Spura KM Bialas J Cordier LJ Albayrak B Felderhoff-Mueser U Huening BM General Movements trajectories and outcome at 12 months in very preterm infants: An analysis of tendencies and pathological persistence Sci Rep 2023 13 1 21825 10.1038/s41598-023-49037-w 38071260
Teschler U, Dathe AK, Heuser-Spura KM, Bialas J, Cordier LJ, Albayrak B, Felderhoff-Mueser U, Huening BM (2023) General Movements trajectories and outcome at 12 months in very preterm infants: An analysis of tendencies and pathological persistence. Sci Rep 13(1):21825. 10.1038/s41598-023-49037-w38071260
28. Wolfsberger CH Pichler-Stachl E Höller N Mileder LP Schwaberger B Avian A Urlesberger B Pichler G Cerebral oxygenation immediately after birth and long-term outcome in preterm neonates-a retrospective analysis BMC Pediatr 2023 23 1 145 10.1186/s12887-023-03960-z 36997902
Wolfsberger CH, Pichler-Stachl E, Höller N, Mileder LP, Schwaberger B, Avian A, Urlesberger B, Pichler G (2023) Cerebral oxygenation immediately after birth and long-term outcome in preterm neonates-a retrospective analysis. BMC Pediatr 23(1):145. 10.1186/s12887-023-03960-z36997902
29. Skworc A Marciniak S Sławska H Influence of infections on the quality of general movements in premature infants Early Hum Dev 2020 148 105118 10.1016/j.earlhumdev.2020.105118 32673903
Skworc A, Marciniak S, Sławska H (2020) Influence of infections on the quality of general movements in premature infants. Early Hum Dev 148:105118. 10.1016/j.earlhumdev.2020.10511832673903
30. Esterman E Goyen TA Jani P Lowe G Baird J Maheshwari R D'Cruz D Luig M Shah D Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants World J Pediatr 2023 19 6 586 594 10.1007/s12519-023-00708-8 36967444
Esterman E, Goyen TA, Jani P, Lowe G, Baird J, Maheshwari R, D’Cruz D, Luig M, Shah D (2023) Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants. World J Pediatr 19(6):586–594. 10.1007/s12519-023-00708-836967444
31. Olsen JE Brown NC Eeles AL Lee KJ Anderson PJ Cheong JL Doyle LW Spittle AJ Trajectories of general movements from birth to term-equivalent age in infants born <30 weeks' gestation Early Hum Dev 2015 91 12 683 688 10.1016/j.earlhumdev.2015.09.009 26513629
Olsen JE, Brown NC, Eeles AL, Lee KJ, Anderson PJ, Cheong JL, Doyle LW, Spittle AJ (2015) Trajectories of general movements from birth to term-equivalent age in infants born <30 weeks’ gestation. Early Hum Dev 91(12):683–688. 10.1016/j.earlhumdev.2015.09.00926513629
32. Einspieler C Prechtl HF Prechtl's assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system Ment Retard Dev Disabil Res Rev 2005 11 1 61 67 10.1002/mrdd.20051 15856440
Einspieler C, Prechtl HF (2005) Prechtl’s assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev 11(1):61–67. 10.1002/mrdd.2005115856440
33. Pichler G Binder C Avian A Beckenbach E Schmölzer GM Urlesberger B Reference ranges for regional cerebral tissue oxygen saturation and fractional oxygen extraction in neonates during immediate transition after birth J Pediatr 2013 163 6 1558 1563 10.1016/j.jpeds.2013.07.007 23972642
Pichler G, Binder C, Avian A, Beckenbach E, Schmölzer GM, Urlesberger B (2013) Reference ranges for regional cerebral tissue oxygen saturation and fractional oxygen extraction in neonates during immediate transition after birth. J Pediatr 163(6):1558–1563. 10.1016/j.jpeds.2013.07.00723972642
34 Souza F A Nogueira C CL Silva A J Chagas P SC Frônio J S Preterm and writhing movements: is it possible to predict fidgety movements in preterm infants? J Perinatol 2021 41 10 2442 2448 10.1038/s41372-021-01064-z 33986474
Souza F A, Nogueira C CL, Silva A J, Chagas P SC, Frônio J S (2021) Preterm and writhing movements: is it possible to predict fidgety movements in preterm infants? J Perinatol 41(10):2442–2448. 10.1038/s41372-021-01064-z33986474
